articleCancer Immunology ImmunotherapyDec 6, 2011GREEN OA

An immune-active tumor microenvironment favors clinical response to ipilimumab

RJRui‐Ru JiSDScott D. ChasalowLWLisu WangOHOmid HamidHSHenrik Schmidt

Bristol-Myers Squibb (United States) · Angeles Clinic and Research Institute · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

No abstract available for this paper.

Citation impact

777
total citations
FWCI
11.64
Percentile
100%
References
52
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Ipilimumab
  • Tumor microenvironment
  • Immune system
  • Medicine
  • Immunotherapy
  • Immunology
  • Cancer research
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.